News - Offer declared wholly unconditional

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD  CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

Recommended Offer by St Helen's Capital Plc on behalf of Accura Pharma Plc for Tridelta Plc

Offer Declared Wholly Unconditional

The Board of Accura Pharma Plc is pleased to announce that all of the conditions relating to the Offer made by St Helen's Capital Plc on behalf of Accura Pharma Plc for the entire  issued and to be issued share capital of Tridelta Plc, as set out in the offer document dated 8 June 2007 (the "Offer Document"), have now been satisfied or waived and that accordingly the Offer is today declared wholly unconditional in all respects as to acceptances.

As at 3.00 p.m. on 13 July 2007, valid acceptances of the Offer had been received in respect of 5,122,121 Tridelta Plc Ordinary Shares, representing approximately 88.21 per cent of the existing issued ordinary share capital of Tridelta Plc. Accura Pharma Plc is delighted by the strong support that the Offer has received. Notice is hereby given that the Offer will remain open for acceptance until further notice, and Tridelta Shareholders who have not yet accepted the Offer are urged to do so as soon as possible.

Accura Pharma plc will, in accordance with s. 204 Irish Companies Act, serve notices to compulsorily acquire any outstanding shares on those Shareholders who have not accepted the Offer by 3 p.m. on 27 July 2007.

Terms defined in the Offer Document have the same meaning in this announcement, unless the context requires otherwise.

The Directors of Accura Pharma Plc accept responsibility for this announcement. To the best of the knowledge and belief of the Accura Pharma Directors (who have taken all reasonable care to ensure that such is the case), the information contained in this announcement for which they are responsible is in accordance with the facts and does not omit anything likely to affect the import of such information.

This announcement does not constitute an offer to sell or an invitation to purchase any securities or the solicitation of an offer to buy any securities.